Health Care & Life Sciences » Biotechnology | Zhongyuan Union Cell & Gene Engineering Corp. Ltd.

Zhongyuan Union Cell & Gene Engineering Corp. Ltd. A | Mutual Funds

Mutual Funds that own Zhongyuan Union Cell & Gene Engineering Corp. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Nanfang CSI 500 ETF
1,251,613
0.33%
-141,900
0.19%
12/31/2017
985,048
0.26%
112,200
4.49%
12/31/2017
780,473
0.2%
-12,400
1.12%
12/31/2017
529,930
0.14%
-43,700
2.8%
12/31/2017
Fund Kexun
300,000
0.08%
0
0.15%
12/31/2017
221,705
0.06%
-11,400
2.7%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
219,183
0.06%
0
0%
07/31/2018
205,968
0.05%
-16,500
0.57%
12/31/2017
190,206
0.05%
21,100
0.43%
12/31/2017
GF CSI 500 ETF
123,531
0.03%
-7,200
0.24%
12/31/2017

About Zhongyuan Union Cell & Gene Engineering Corp.

View Profile
Address
Huayuan Industrial Park
Tianjin Tianjin 300384
China
Employees -
Website http://www.vcanbio.com
Updated 07/08/2019
Zhongyuan Union Cell & Gene Engineering Corp., Ltd. engages in the development of life sciences technology. Its business activities include stem cell genetic engineering, venture capital, investment banking, and investment consulting. It also engages in the import and export of goods and technology.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.